Professor Christian Ottensmeier

Research Grants

Immunological stratification of Head and neck squamous cell carcinomas to guide treatment choices with immunotherapy (Akoya)

THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST (UK)

May 2023 - May 2024

LAG-3 expression in solid tumours

BRISTOL-MYERS SQUIBB PHARMACEUTICALS LTD (UK)

March 2022 - September 2022

Epigenomic and Transcriptomic Profile of Human Immune Cells

NATIONAL INSTITUTES OF HEALTH (USA)

August 2021 - July 2024

Respiratory pathogen-specific T cell signatures following vaccinationt, natural infection, and treatment

NATIONAL INSTITUTES OF HEALTH (USA)

June 2022 - May 2027

Understanding recognition of tumour antigens by T-cells in NSCLC for cancer vaccine development

NORTH WEST CANCER RESEARCH INCORPORATING CLATTERBRIDGE CANCER RESEARCH (UK)

April 2024 - March 2026

AST-VAC sequencing project

CANCER RESEARCH UK (UK)

November 2023 - September 2024

Akoya Biosciences Phenocycler Fusion

THE CLATTERBRIDGE CANCER CHARITY (UK)

October 2022 - October 2023

Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses

NATIONAL INSTITUTES OF HEALTH (USA)

March 2023 - February 2024

The tumour microenvironment and the effect that various treatments and vaccines have on the immune cells within the tumour

SOUTHAMPTON HOSPITALS CHARITY (UK)

October 2021 - October 2028

LHNC Stage 2: consolidation for clinical impact

NORTH WEST CANCER RESEARCH INCORPORATING CLATTERBRIDGE CANCER RESEARCH (UK)

November 2023 - March 2028

Targeting non-small cell lung cancer with personalised doggybone DNA vaccines (db-PCV) (NEOVACC)

MEDICAL RESEARCH COUNCIL

December 2023 - November 2027

PROTIS: A phase III trial of proton beam therapy versus intensity-modulated radiotherapy for the treatment of sinonasal malignancy (PROTIS)

CANCER RESEARCH UK (UK)

March 2022 - March 2031

Liverpool ECMC (LECMC)

CANCER RESEARCH UK (UK)

April 2023 - March 2028